An NCI-designated Comprehensive Cancer Center
Larry Kwak
City of Hope Cancer and Diabetes Leaders Win Prestigious Awards
April 15, 2020 | by City of Hope
City of Hope’s cancer and diabetes leaders have won a series of important awards recently, including induction into the 2020 class of American Institute for Medical and Biological Engineering (AIMBE) Fellows and the Edwin L. Bierman Lectureship by the American Diabetes Association (ADA).
Awards
Steven Smith
Steven Smith, Ph.D. and City of Hope Scientists Unveil New Research on Cancer and Aging
March 18, 2020 | by City of Hope
City of Hope scientists have developed an approach to detecting sites of replication stress linked to the failure of suppression systems in human cancer and aging that normally take these strange structures apart. A study about that approach published in Cancer Genomics and Proteomics.
Clinical Trials/Studies
Eileen Smith
Eileen Smith, M.D., Named
Hematology Head at City of Hope
March 2, 2020 | by Letisia Marquez
Stephen J. Forman, M.D., is transitioning from chair of City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation, Eileen Smith, M.D., is appointed as new chair
Faculty
Weitzel 256x256
$8.5M grant fuels research into rare genetic disorder
January 10, 2020 | by Letisia Marquez
The National Institutes of Health funding will support a City of Hope study of a rare cancer-causing syndrome linked to an inherited mutation in the TP53 gene. Li-Fraumeni syndrome causes various cancers early in life.
Clinical Trials/Studies
brain tumor
New immunotherapy trial targets recurrent glioblastoma
January 10, 2020 | by Letisia Marquez
City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma. To launch the randomized trial, the National Institutes of Health awarded $3.3 million over five years to Behnam Badie, M.D. and Christine Brown, Ph.D. Brown and Badie also received $800,000 from Gateway for Cancer Research.
Clinical Trials/Studies
Chen-Shiuan
Chen Receives $3.3M Grant
for Prostate Mushroom Study
January 9, 2020 | by C. Pete Lee
Shiuan Chen, Ph.D., who heads City of Hope’s Natural Therapies Program, is studying the effects of white button mushrooms on prostate cancer patients. He previously found that phytochemicals in mushrooms had the ability to block the activity of an enzyme that contributes to breast cancer.
Clinical Trials/Studies